查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012941

腦監測設備市場：按產品類型、技術、應用和最終用戶分類 - 2026-2032年全球市場預測

Brain Monitoring Devices Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，腦監測設備市場價值將達到 30.2 億美元，到 2026 年將成長至 32.2 億美元，到 2032 年將達到 51.5 億美元，複合年成長率為 7.91%。

主要市場統計數據
基準年 2025 30.2億美元
預計年份：2026年 32.2億美元
預測年份 2032 51.5億美元
複合年成長率 (%) 7.91%

對正在重塑臨床和研究環境中腦監測的技術、臨床和護理服務趨勢進行了簡潔且具有前瞻性的概述。

隨著感測技術、計算分析和醫療服務模式的整合發展，腦監測設備領域正在迅速演變，重新定義了神經系統評估和持續監測。臨床醫生正在尋求能夠提供更高診斷準確性並適應日益分散的醫療服務路徑的工具。同時，研究人員和設備開發人員也在積極探索各種方法，以減少就醫障礙，提高患者舒適度，並將監測範圍從一次性諮詢擴展到收集長期真實世界數據。

詳細說明了技術創新、分析突破和醫療保健服務變革的融合如何改變腦監測的功能和廣泛應用。

近年來，一系列變革性的變化重新定義了腦監測設備的功能和應用場景。其中一個主要轉變是從大型固定式設備向攜帶式穿戴式平台的過渡，這些平台能夠在傳統臨床環境之外進行連續或移動監測。同時，結合腦電圖、光學成像、磁振造影和代謝成像的多模態方法也迅速普及，這些方法能夠提供關於腦部功能的互補觀點。

對 2025 年美國關稅變化將如何影響各設備類別的採購趨勢、供應鏈和製造商策略進行策略評估。

美國2025年實施的關稅調整對腦監測設備的整個價值鏈產生了複雜的連鎖反應。關鍵零件和完整成像系統的進口關稅增加了醫療機構和研究機構的採購成本，迫使採購負責人重新評估供應商選擇標準和整體擁有成本（TCO）。因此，一些買家推遲了資本財的採購，或優先選擇具有本地生產能力的供應商，以降低關稅風險。

透過對細分市場、技術、應用、最終用戶和產品類型的全面洞察，指導有針對性的產品開發和商業化策略。

深入了解市場區隔對於推動整個腦監測市場的產品開發、商業化和臨床部署策略至關重要。從技術角度來看，該市場涵蓋電腦斷層掃描 (CT)、腦電圖 (EEG)、功能性近紅外線光譜 (fNIRS)、磁振造影(MRI)、腦磁圖 (MEG) 和正子斷層掃描 (PET)，每種技術都具有其獨特的技術特性和臨床效用。電腦斷層掃描 (CT) 又可進一步分為錐狀射束CT、常規 CT 和頻譜CT，它們在空間解析度、輻射計量特性和應用領域方面存在差異。腦電圖 (EEG) 包括攜帶式EEG、連續 EEG 監測、常規 EEG 和睡眠 EEG。攜帶式EEG 又可分為非穿戴式和穿戴式式，其中穿戴式式裝置又可細分為帽式（注重全面覆蓋）和頭帶式（注重用戶便利性）。功能性近紅外線光譜技術分為連續波、頻域和時域技術，其中頻域技術根據多距離和單距離配置進行區分，這會影響深度靈敏度和定量分析。磁振造影（MRI）包括常規MRI、高場MRI和低場MRI，高場系統又分為標準高場平台和超高場平台，後者可提供更高的對比和解析度。磁性電腦電圖（MEG）分為基於光激勵磁力計（OPM）的系統和基於超導量子乾涉裝置（SQUID）的系統，OPM平台又分為連續OPM和零場OPM。正子斷層掃描（PET）產品線包括PET/CT一體機、PET/MRI混合系統和獨立PET系統，每種系統都針對不同的診斷流程進行了最佳化。

區域洞察：醫療保健基礎設施、管理體制和製造地的差異如何影響世界各地的部署模式。

由於醫療基礎設施、法規環境以及研發生態系統的差異，區域趨勢呈現明顯的模式。在美洲，強大的臨床研究基礎和對先進診斷及監測能力的旺盛需求顯而易見，重點在於能夠融入醫院工作流程並支持門診服務擴展的解決方案。報銷機制和臨床醫生對先進影像技術的熟練程度會影響技術的採用率，而在地化生產也在探索之中，以緩解關稅帶來的成本壓力。

對大腦監測生態系統中定義領導地位和差異化的競爭定位、夥伴關係模式和策略措施進行詳細分析。

腦監測設備生態系統的競爭動態由成熟的影像和診斷設備製造商、專注於神經技術的Start-Ups、軟體分析供應商和組件供應商共同塑造。老字型大小企業通常憑藉廣泛的系統產品組合、完善的服務網路和深入的臨床檢驗展開競爭，而專業供應商則專注於特定領域的性能優勢、創新外形規格或針對特定臨床工作流程的軟體差異化。Start-Ups往往在穿戴式腦電圖 (EEG)、可攜式腦磁圖 (MEG) 和非侵入式光學感測等領域推動產品快速改進，而以軟體為先的公司則優先考慮分析功能、雲端連接和互通性，以探索新的應用情境。

為高階主管提供有針對性、可操作的建議，以加強供應鏈韌性，加速軟體主導的差異化，並將循證策略與商業性目標一致。

產業領導者應採取平衡策略，使產品創新與實際的商業性和營運需求相契合。首先，供應鏈多元化並考慮關鍵零件的近岸外包，可以降低關稅波動風險，提高應對力。製造商應優先考慮模組化產品架構，以便於零件替換和快速配置變更，從而滿足不同的臨床和區域需求。這種設計柔軟性可以縮短產品上市時間，並減輕供應中斷的影響。

我們透明的調查方法結合了與主要相關人員的訪談、技術檢驗和情境分析，為相關人員提供可操作的、基於證據的見解。

本分析的調查方法結合了與領域專家的直接對話、嚴謹的技術審查和全面的二次檢驗，從而確保了分析結果的可靠性和可操作性。關鍵資料來源包括與臨床醫生、生物醫學工程師、採購負責人和醫療設備開發人員的結構化訪談，旨在收集關於臨床效用、採購標準和技術推廣障礙的第一手觀點。這些對話加深了我們對實際工作流程和未解決的需求的理解，而這些需求和需求又會影響醫療設備的需求和證據優先順序。

明確且具有策略意義的結論，強調技術潛力、營運韌性和主導商業化之間的交集，以實現長期影響。

總之，腦監測設備市場正經歷一場關鍵性的變革，其驅動力包括技術小型化、先進分析以及向分散式醫療模式的轉變。這些因素為攜帶式、穿戴式式和多模態解決方案創造了新的機遇，使監測範圍能夠從醫院擴展到門診和居家照護環境。同時，政策變化和價格調整也給供應鏈和採購帶來了壓力，迫使製造商和買家重新評估其採購方式、產品架構和定價策略。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 腦監測設備市場：依產品類型分類

  • 配件
    • 帽子
    • 電極
    • 感應器
  • 軟體
    • 分析軟體
    • 資料管理軟體
  • 系統
    • 可攜式系統
    • 靜止系統

第9章：腦監測設備市場：依技術分類

  • CT
    • 錐狀射束CT
    • 常規CT
    • 頻譜CT
  • 腦電圖（EEG）
    • 攜帶式腦電圖
      • 不穿戴式
      • 穿戴式裝置
      • 帽型
      • 頭帶類型
    • 連續腦電圖監測
    • 常規腦電圖
    • 睡眠腦電圖
  • FNIRS
    • 連續波
    • 頻域
      • 多距離
      • 單距離
    • 時域
  • 磁振造影
    • 常規磁振造影
    • 高場磁振造影
      • 標準高場
      • 超高磁場
    • 低場磁振造影
  • 腦磁圖
    • OPM 基礎
      • 環境 OPM
      • 零磁場 OPM
    • SQUID方法
  • PET
    • PET/CT
    • PET/MRI
    • 獨立式PET

第10章：腦監測設備市場：依應用領域分類

  • 臨床診斷
  • 居家照護
  • 研究

第11章 腦監測設備市場：依最終用戶分類

  • 診斷中心
  • 居家照護設施
  • 醫院
  • 研究機構
    • 政府機構
    • 私營機構

第12章 腦監測設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：腦監測設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 腦監測設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國腦監測設備市場

第16章：中國腦監測設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Brain Products GmbH
  • Cadwell Industries, Inc.
  • Cadwell Laboratories, Inc.
  • CAS Medical Systems, Inc.
  • Compumedics Limited
  • Dragerwerk AG & Co. KGaA
  • Elekta AB
  • EMOTIV Inc.
  • g.tec medical engineering GmbH
  • General Electric Company
  • Integra LifeSciences Corporation
  • Koninklijke Philips NV
  • Lifelines Neurodiagnostic Systems, Inc.
  • Medtronic plc
  • Mindray Medical International Limited
  • Natus Medical
  • Natus Medical Incorporated
  • Neural Analytics, Inc.
  • Neurosoft Ltd.
  • Nihon Kohden Corporation
  • Nonin Medical, Inc.
  • Rimed Inc.
  • Yokogawa Electric Corporation
Product Code: MRR-437D4595861A

The Brain Monitoring Devices Market was valued at USD 3.02 billion in 2025 and is projected to grow to USD 3.22 billion in 2026, with a CAGR of 7.91%, reaching USD 5.15 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.02 billion
Estimated Year [2026] USD 3.22 billion
Forecast Year [2032] USD 5.15 billion
CAGR (%) 7.91%

A concise and forward-looking introduction to the shifting technological, clinical, and care delivery forces reshaping brain monitoring across clinical and research settings

The landscape of brain monitoring devices is evolving rapidly as advances in sensing technology, computational analytics, and care delivery models converge to redefine neurological assessment and continuous monitoring. Clinicians are seeking tools that deliver higher diagnostic confidence while fitting into increasingly decentralized care pathways. At the same time, researchers and device developers are pushing for modalities that reduce barriers to access, improve patient comfort, and extend monitoring beyond episodic encounters into longitudinal, real-world data capture.

In parallel, improvements in signal processing, miniaturized sensors, and low-field imaging platforms are creating opportunities for new device form factors and use cases. These technological enablers are further amplified by the maturation of software-driven analytics, which transform raw physiological signals into actionable insights for diagnosis, treatment planning, and outcome tracking. As a result, stakeholders across healthcare, research, and home care contexts are reevaluating clinical workflows and procurement priorities to incorporate solutions that balance performance, usability, and cost-effectiveness.

Regulatory pathways and reimbursement environments are also adapting, prompting manufacturers and healthcare providers to align product development and evidence-generation strategies closely with clinical needs. Collectively, these dynamics are accelerating the transition from purely hospital-centric imaging and monitoring to hybrid models that integrate hospital, outpatient, and home-based monitoring, thereby expanding the role of brain monitoring devices in both acute and chronic care management.

An in-depth account of the converging technological innovations, analytics breakthroughs, and care delivery shifts that are transforming brain monitoring capabilities and adoption

Recent years have seen a series of transformative shifts that are redefining what brain monitoring devices can achieve and where they can be deployed. A primary shift is the transition from large, stationary instruments toward portable and wearable platforms that enable continuous or ambulatory monitoring outside traditional clinical environments. This movement is accompanied by a proliferation of multimodal approaches that combine electroencephalography with optical, magnetic, and metabolic imaging to provide complementary perspectives on brain function.

Another major transformation is the integration of advanced analytics, including machine learning and cloud-based pipelines, which convert complex physiological datasets into clinically relevant outputs. These analytics enable faster interpretation, pattern recognition across large cohorts, and predictive modeling that supports early intervention. Concurrently, hardware innovations-such as compact sensor arrays, low-field magnetic resonance imaging systems, and optically pumped magnetometers-are lowering the barriers to adoption by reducing cost, footprint, and operational complexity.

Ecosystem-level changes are also notable. The proliferation of home care and ambulatory applications is shifting centricity toward patient convenience and long-term monitoring, necessitating stronger emphasis on device comfort, data security, and remote device management. Supply chain diversification and onshoring initiatives are influencing manufacturing strategies, while evolving regulatory expectations demand robust clinical validation and post-market surveillance. Taken together, these shifts are not isolated; they compound each other to reshape product roadmaps, reimbursement strategies, and clinical workflows across acute care, outpatient settings, and research environments.

A strategic assessment of how the United States tariff changes in 2025 altered procurement dynamics, supply chains, and manufacturer strategies across device categories

The tariff adjustments introduced in the United States in 2025 have created a complex set of consequences that reverberate across the brain monitoring device value chain. Import levies on key components and finished imaging systems have increased procurement costs for healthcare providers and research institutions, prompting procurement officers to reassess vendor selection criteria and total cost of ownership. As a result, some buyers are delaying capital purchases or favoring suppliers with localized manufacturing footprints to mitigate tariff exposure.

These changes have ripple effects across product categories. High-capital systems, including advanced magnetic resonance platforms and integrated PET solutions, face particular sensitivity to component price inflation and logistics constraints. At the same time, the accessories and consumables ecosystem-caps, electrodes, sensors-has experienced tighter margin pressure, which challenges distributors and hospital supply managers to renegotiate contracts or seek alternative suppliers. For software-centric vendors, tariffs on computing hardware and peripheral devices affect deployment strategies, particularly for bundled offerings that include edge processing units or specialized servers.

Manufacturers are responding with strategic shifts that include nearshoring of production, diversification of supplier bases, and reengineering of product designs to reduce dependency on tariffed components. These strategic moves often require upfront capital and a recalibration of inventory and logistics practices. Procurement implications are amplified in settings where budgets are constrained, such as public hospitals and certain research institutes, which may prioritize cost containment over early adoption of the latest modalities. In sum, the 2025 tariff landscape has accelerated supply-side restructuring and introduced demand-side caution, reshaping procurement timelines and product strategies across the ecosystem.

Comprehensive segmentation insights that map technologies, applications, end users, and product types to guide targeted product development and commercialization strategies

A granular understanding of segmentation is essential to navigate product development, commercialization, and clinical adoption strategies across the brain monitoring landscape. From a technology perspective, the market encompasses computed tomography, electroencephalography, functional near-infrared spectroscopy, magnetic resonance imaging, magnetoencephalography, and positron emission tomography, each with distinct technical attributes and clinical utilities. Computed tomography is differentiated across cone beam CT, conventional CT, and spectral CT, which vary in spatial resolution, dose characteristics, and application focus. Electroencephalography spans ambulatory EEG, continuous EEG monitoring, routine EEG, and sleep EEG, with ambulatory modalities further bifurcating into non-wearable and wearable formats, and wearable devices subdivided into cap-based and headband-based designs that prioritize either comprehensive coverage or user convenience. Functional near-infrared spectroscopy is divided into continuous wave, frequency domain, and time domain technologies, with frequency domain approaches further differentiated by multi-distance and single-distance configurations that affect depth sensitivity and quantification. Magnetic resonance imaging includes conventional MRI, high field MRI, and low field MRI, where high field systems are further distinguished between standard high field and ultra high field platforms that drive advanced contrast and resolution. Magnetoencephalography is distinguished between optically pumped magnetometer-based systems and SQUID-based systems, with OPM platforms further categorized into ambient OPM and zero field OPM variants. Positron emission tomography offerings include integrated PET/CT, hybrid PET/MRI, and standalone PET systems, each optimized for different diagnostic workflows.

Analyzing applications reveals three primary use cases: clinical diagnostics, home care, and research. Clinical diagnostics prioritize robustness, regulatory clearance, and integration into established care pathways. Home care emphasizes ease of use, comfort, and remote data transmission capabilities to support longitudinal monitoring and chronic disease management. Research applications demand flexibility, raw data access, and modalities suited to experimental protocols.

End users cut across diagnostics centers, home care settings, hospitals, and research institutes, with research institutes subdivided into governmental and private entities that have differing procurement cycles and funding models. Diagnostics centers typically focus on throughput and cost-efficiency, hospitals on versatility and integration with electronic health records, home care settings on patient experience and remote monitoring infrastructure, and research institutes on customization and data fidelity.

Product types span accessories, software, and systems. Accessories encompass caps, electrodes, and sensors that directly influence signal quality and patient comfort. Software includes analysis software and data management software, which are core to translating physiological signals into clinical insights and enabling secure longitudinal data storage. Systems are categorized into portable systems and stationary systems, reflecting trade-offs between mobility and advanced imaging performance. Understanding these segmentation dimensions in tandem enables stakeholders to identify niches for innovation, prioritize evidence generation, and tailor commercial strategies to the specific demands of each buyer group.

Region-specific insights describing how differing healthcare infrastructure, regulatory regimes, and manufacturing footprints dictate adoption patterns across global territories

Regional dynamics exhibit distinct patterns driven by differences in healthcare infrastructure, regulatory environments, and R&D ecosystems. The Americas reflect a strong clinical research base and high demand for advanced diagnostic and monitoring capabilities, with emphasis on solutions that integrate into hospital workflows and support outpatient expansions. Reimbursement frameworks and clinician familiarity with advanced imaging modalities influence adoption velocity, and localized manufacturing initiatives are being explored to mitigate tariff-driven cost pressures.

Europe, Middle East & Africa present a heterogeneous landscape where regulatory harmonization in certain areas supports cross-border device approvals, yet varying healthcare budgets and infrastructure create distinct market niches. In parts of this region, public health programs and academic research centers drive demand for versatile systems and flexible acquisition models, while other markets prioritize cost-effective, portable solutions suitable for decentralized care delivery. Supply chain resilience and compliance with diverse regulatory regimes are key considerations for vendors operating across this broad region.

Asia-Pacific is characterized by rapid adoption of innovative device form factors and a robust manufacturing base that supports both original equipment production and component supply. Large urban centers with sizable patient volumes drive interest in high-throughput diagnostics, while emerging markets within the region prioritize low-cost, easy-to-deploy systems and remote monitoring technologies to address access gaps. Regional partnerships and local regulatory engagement are effective strategies for market entry and scale in this diverse landscape.

Taken together, regional strategies must balance global product standardization with local adaptations in pricing, evidence generation, and service models. Manufacturers that align product roadmaps with region-specific reimbursement, regulatory, and clinical practice realities are positioned to capture broader adoption across these distinct geographies.

A nuanced view of competitive positioning, partnership models, and strategic moves that define leadership and differentiation within the brain monitoring ecosystem

Competitive dynamics in the brain monitoring device ecosystem are shaped by a mix of established imaging and diagnostics firms, specialized neurotechnology startups, software analytics vendors, and component suppliers. Established firms typically compete on the basis of broad systems portfolios, service networks, and deep clinical validation, whereas specialist vendors focus on niche performance advantages, innovative form factors, or software-enabled differentiation that targets specific clinical workflows. Startups often drive rapid iteration in wearable EEG, portable MEG, and noninvasive optical sensing, while software-first companies emphasize analytics, cloud connectivity, and interoperability to unlock new use cases.

Collaboration is a defining feature of the landscape: partnerships between device manufacturers and analytics providers accelerate the translation of raw signals into decision-ready outputs, and alliances with research institutes enable rigorous validation studies that support clinical adoption. Similarly, component suppliers and contract manufacturers play a critical role in determining product cost structures and time-to-market, especially as firms respond to supply chain pressures and tariff-driven cost shifts.

Strategic corporate actions such as targeted acquisitions, licensing deals, and co-development agreements are common as companies seek to expand capabilities or enter adjacent clinical segments. Service and maintenance offerings, training programs, and managed services have emerged as important differentiators that enhance customer retention and lifetime value. Overall, the competitive environment rewards organizations that combine technical excellence with scalable commercialization models and strong clinical partnerships.

Targeted and actionable recommendations for executives to strengthen supply resilience, accelerate software-driven differentiation, and align evidence strategies with commercial goals

Industry leaders should pursue a balanced strategy that aligns product innovation with pragmatic commercial and operational imperatives. First, diversifying supply chains and evaluating nearshoring for critical components will reduce exposure to tariff volatility and improve responsiveness. Manufacturers should prioritize modular product architectures that allow substitution of components and facilitate rapid configuration for different clinical and regional requirements. This engineering flexibility will accelerate time-to-market and lower the impact of supply disruptions.

Second, investing in robust software and analytics capabilities is essential. Software not only enhances device value through improved interpretation and workflow integration, but also creates recurring revenue opportunities and strengthens customer lock-in. Leaders should build interoperable platforms that support standardized data formats, secure cloud connectivity, and clinician-centric interfaces to facilitate adoption across hospitals, diagnostics centers, and home care settings.

Third, evidence generation and regulatory strategy must be tightly coordinated. Prioritizing clinical studies that demonstrate real-world utility, cost-effectiveness, and patient-centered outcomes will streamline payer engagement and support reimbursement discussions. Engaging early with regulators and payers enables more predictable pathways for clearance and coverage. Additionally, companies should expand service offerings and training programs to ensure optimal clinical integration and to reduce the burden on end users.

Finally, strategic partnerships with research institutes, local distributors, and technology providers can accelerate market entry and scale. Joint initiatives that combine hardware, software, and clinical expertise will be particularly effective in demonstrating value in specialty areas such as continuous monitoring, neurocritical care, and home-based chronic disease management. By aligning operational resilience, software differentiation, clinical evidence, and collaborative go-to-market strategies, industry leaders can navigate current headwinds and capture growth opportunities across diverse care settings.

A transparent methodology combining primary stakeholder interviews, technical validation, and scenario analysis to produce actionable and evidence-based insights for stakeholders

The research methodology underpinning this analysis combines primary engagement with domain experts, rigorous technical review, and comprehensive secondary validation to ensure robust and actionable insights. Primary inputs include structured interviews with clinicians, biomedical engineers, procurement professionals, and device developers to capture firsthand perspectives on clinical utility, procurement criteria, and technology adoption barriers. These conversations inform an understanding of real-world workflows and unmet needs that shape device requirements and evidence priorities.

Secondary analysis synthesizes peer-reviewed literature, regulatory approvals and guidance documents, patent filings, and clinical trial registries to assess technology maturity and validate claims about performance and safety. Supply chain mapping and component-level assessment provide visibility into manufacturing dependencies, logistics pathways, and potential bottlenecks. Comparative technology assessments evaluate trade-offs among modalities in terms of sensitivity, specificity, usability, and integration complexity.

Scenario-based analysis explores the implications of policy shifts, tariff changes, and technological breakthroughs on adoption pathways and procurement decisions. Cross-validation across multiple data streams ensures that conclusions are corroborated and that recommendations remain grounded in practical constraints. Throughout, the methodology emphasizes transparency in assumptions and a focus on evidence that supports adoption, regulatory clearance, and integration into clinical practice.

A decisive and strategic conclusion emphasizing the intersection of technological promise, operational resilience, and evidence-driven commercialization for long-term impact

In conclusion, the brain monitoring device landscape is undergoing a pivotal transformation driven by technological miniaturization, advanced analytics, and a shift toward decentralized care models. These forces are creating new opportunities for portable, wearable, and multimodal solutions that can extend monitoring beyond hospitals into outpatient and home care settings. At the same time, policy changes and tariff adjustments are exerting pressure on supply chains and procurement, prompting manufacturers and buyers to rethink sourcing, product architecture, and pricing strategies.

The ability to succeed in this environment depends on aligning engineering flexibility with strong software capabilities and a disciplined evidence-generation strategy that speaks to clinicians, payers, and procurement authorities. Regional nuances matter: adoption pathways differ across the Americas, Europe, Middle East & Africa, and Asia-Pacific, and companies must tailor approaches to local regulatory, reimbursement, and infrastructure realities. By focusing on modularity, interoperability, clinical validation, and supply resilience, stakeholders can translate emerging technological promise into scalable clinical impact and sustainable commercial models.

Ultimately, the organizations that integrate technical innovation with pragmatic commercialization and strategic partnerships will be best positioned to deliver meaningful improvements in neurological care and to capture long-term opportunities across clinical and research domains.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Brain Monitoring Devices Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Caps
    • 8.1.2. Electrodes
    • 8.1.3. Sensors
  • 8.2. Software
    • 8.2.1. Analysis Software
    • 8.2.2. Data Management Software
  • 8.3. Systems
    • 8.3.1. Portable Systems
    • 8.3.2. Stationary Systems

9. Brain Monitoring Devices Market, by Technology

  • 9.1. CT
    • 9.1.1. Cone Beam CT
    • 9.1.2. Conventional CT
    • 9.1.3. Spectral CT
  • 9.2. Electroencephalography
    • 9.2.1. Ambulatory EEG
      • 9.2.1.1. Non Wearable
      • 9.2.1.2. Wearable
      • 9.2.1.2.1. Cap Based
      • 9.2.1.2.2. Headband Based
    • 9.2.2. Continuous EEG Monitoring
    • 9.2.3. Routine EEG
    • 9.2.4. Sleep EEG
  • 9.3. FNIRS
    • 9.3.1. Continuous Wave
    • 9.3.2. Frequency Domain
      • 9.3.2.1. Multi Distance
      • 9.3.2.2. Single Distance
    • 9.3.3. Time Domain
  • 9.4. Magnetic Resonance Imaging
    • 9.4.1. Conventional MRI
    • 9.4.2. High Field MRI
      • 9.4.2.1. Standard High Field
      • 9.4.2.2. Ultra High Field
    • 9.4.3. Low Field MRI
  • 9.5. Magnetoencephalography
    • 9.5.1. OPM Based
      • 9.5.1.1. Ambient OPM
      • 9.5.1.2. Zero Field OPM
    • 9.5.2. SQUID Based
  • 9.6. PET
    • 9.6.1. PET/CT
    • 9.6.2. PET/MRI
    • 9.6.3. Standalone PET

10. Brain Monitoring Devices Market, by Application

  • 10.1. Clinical Diagnostics
  • 10.2. Home Care
  • 10.3. Research

11. Brain Monitoring Devices Market, by End User

  • 11.1. Diagnostics Centers
  • 11.2. Home Care Settings
  • 11.3. Hospitals
  • 11.4. Research Institutes
    • 11.4.1. Government Institutes
    • 11.4.2. Private Institutes

12. Brain Monitoring Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Brain Monitoring Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Brain Monitoring Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Brain Monitoring Devices Market

16. China Brain Monitoring Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. B. Braun Melsungen AG
  • 17.6. Becton, Dickinson and Company
  • 17.7. Brain Products GmbH
  • 17.8. Cadwell Industries, Inc.
  • 17.9. Cadwell Laboratories, Inc.
  • 17.10. CAS Medical Systems, Inc.
  • 17.11. Compumedics Limited
  • 17.12. Dragerwerk AG & Co. KGaA
  • 17.13. Elekta AB
  • 17.14. EMOTIV Inc.
  • 17.15. g.tec medical engineering GmbH
  • 17.16. General Electric Company
  • 17.17. Integra LifeSciences Corporation
  • 17.18. Koninklijke Philips N.V.
  • 17.19. Lifelines Neurodiagnostic Systems, Inc.
  • 17.20. Medtronic plc
  • 17.21. Mindray Medical International Limited
  • 17.22. Natus Medical
  • 17.23. Natus Medical Incorporated
  • 17.24. Neural Analytics, Inc.
  • 17.25. Neurosoft Ltd.
  • 17.26. Nihon Kohden Corporation
  • 17.27. Nonin Medical, Inc.
  • 17.28. Rimed Inc.
  • 17.29. Yokogawa Electric Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRAIN MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BRAIN MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BRAIN MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BRAIN MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTRODES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTRODES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTRODES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STATIONARY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STATIONARY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STATIONARY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONE BEAM CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SPECTRAL CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SPECTRAL CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SPECTRAL CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAP BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAP BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAP BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HEADBAND BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HEADBAND BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HEADBAND BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS EEG MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS EEG MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS EEG MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ROUTINE EEG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ROUTINE EEG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ROUTINE EEG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SLEEP EEG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SLEEP EEG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SLEEP EEG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MULTI DISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MULTI DISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MULTI DISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SINGLE DISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SINGLE DISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SINGLE DISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TIME DOMAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TIME DOMAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TIME DOMAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDARD HIGH FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDARD HIGH FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDARD HIGH FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ULTRA HIGH FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ULTRA HIGH FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ULTRA HIGH FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY LOW FIELD MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY LOW FIELD MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY LOW FIELD MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBIENT OPM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBIENT OPM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBIENT OPM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ZERO FIELD OPM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ZERO FIELD OPM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ZERO FIELD OPM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SQUID BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SQUID BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SQUID BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDALONE PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDALONE PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDALONE PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY GOVERNMENT INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY GOVERNMENT INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRIVATE INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRIVATE INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRIVATE INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, 2018-2032 (USD MILLION)
  • TABLE 193. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 282. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 284. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 286. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 288. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2032 (USD MILLION)
  • TABLE 290. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, 2018-2032 (USD MILLION)
  • TABLE 292. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, 2018-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 294. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, 2018-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 296. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, 2018-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 298. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 301. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 302. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 304. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 305. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 306. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 308. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 309. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2032 (USD MILLION)
  • TABLE 310. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 311. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS,